D-dimer and duration of anticoagulation [12]

New England Journal of Medicine

Volumn 356, Issue 4, 2007, Pages 421-423

  Pernod, Gilles ^a   Sevestre, Marie Antoinette ^b   Labarere, Jose ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; UNCLASSIFIED DRUG; VITAMIN K GROUP;

CONFIDENCE INTERVAL; ECHOGRAPHY; HAZARD RATIO; HUMAN; INCIDENCE; LETTER; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; BLOOD; BLOOD ANALYSIS; DRUG ANTAGONISM; LUNG EMBOLISM; METHODOLOGY; NOTE; VEIN THROMBOSIS; AGE; AGED;

ANTICOAGULANTS; BLOOD CHEMICAL ANALYSIS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PULMONARY EMBOLISM; VENOUS THROMBOSIS; VITAMIN K; AGE FACTORS; AGED; RECURRENCE; RISK FACTORS;

EID: 33846461309     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc063267     Document Type: Letter

References (3)

1. Palareti G, Cosmi B, Legnani C, et al. D-Dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006;355:1780-9.
2. Barro C, Bosson JL, Pernod G, Carpentier PH, Polack B. Plasma D-dimer testing improves the management of thromboembolic disease in hospitalized patients. Thromb Res 1999;95:263-9.
3. Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G. D-Dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost 2005;94:969-74.